Better Care for PFAS Patients Act of 2026

This bill would require the federal Agency for Toxic Substances and Disease Registry to sign an agreement, within 60 days, with the National Academies of Sciences, Engineering, and Medicine (or another entity) to study the health effects of PFAS chemicals that can be measured in the human body. The study and clinical recommendations would be due within 2 years and updated every 5 years or more often. The study group would have to gather input from communities exposed to PFAS. The agency would then issue clinical guidance for doctors within 5 years, post it online, share it with state and local health officials and health care providers, and update it every 5 years or more often.

Full text and official record on Congress.gov

Sponsors

• Maxine Dexter Democrat sponsor
• 1 cosponsors